Skip to main content
. Author manuscript; available in PMC: 2015 Sep 5.
Published in final edited form as: N Engl J Med. 2015 Mar 5;372(10):923–932. doi: 10.1056/NEJMoa1413204

Figure 2. Disease-free and Overall Survival.

Figure 2

The 4-year estimates of disease-free survival (Panel A) and overall survival (Panel B) are Kaplan–Meier estimates. With respect to disease-free survival, there were 12 relapses or deaths in the chemotherapy-plus-goserelin group and 24 in the chemotherapy-alone group; with respect to overall survival, there were 8 deaths in the chemotherapy-plus-goserelin group and 17 in the chemotherapy-alone group.